Tech Company Financing Transactions
Renovar Funding Round
On 11/30/2006, Renovar raised $1.2 million in Series B funding from NEW Capital Fund and Wisconsin Investment Partners.
Transaction Overview
Company Name
Announced On
11/30/2006
Transaction Type
Venture Equity
Amount
$1,220,000
Round
Series B
Investors
NEW Capital Fund (Charlie Goff)
Proceeds Purpose
Peggy Hedberg, president and chief executive of Renovar said, "These new funds enable us to aggressively push our marquee product toward FDA clearance, a key milestone in the company's development."
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
200 E Washington
Appleton, WI 54911
USA
Appleton, WI 54911
USA
Phone
Undisclosed
Website
Email Address
Overview
Our goal at Renovar is to work collaboratively to help you achieve your research goals as quickly, easily and cost-effectively as possible. Our scientists can provide start-to-finish support for your research study, including biomarker selection and assay panel development, study design and data analysis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Stuart Knechtle
Chief Executive Officer
Peggy Hedberg
Founder
Terry Sivesind
Browse more venture capital transactions:
Prev: 11/30/2006: Concert Pharmaceuticals venture capital transaction
Next: 11/30/2006: OpenSpan Software venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs